Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Change in Accured Expenses (2018 - 2025)

Viemed Healthcare's Change in Accured Expenses history spans 8 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 406.93% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached $255000.0, down 91.07%, while the annual FY2025 figure was $255000.0, 91.07% down from the prior year.
  • Change in Accured Expenses reached -$1.3 million in Q4 2025 per VMD's latest filing, down from $3.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $3.6 million in Q3 2025 to a low of -$3.7 million in Q2 2021.
  • Average Change in Accured Expenses over 5 years is $329900.0, with a median of $73500.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: soared 3559.55% in 2022, then plummeted 406.93% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at -$311000.0 in 2021, then crashed by 99.68% to -$621000.0 in 2022, then soared by 240.58% to $873000.0 in 2023, then tumbled by 50.4% to $433000.0 in 2024, then tumbled by 406.93% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for VMD's Change in Accured Expenses are -$1.3 million (Q4 2025), $3.6 million (Q3 2025), and $1.1 million (Q2 2025).